liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Apoptins: selective anticancer agents
Linköping University, Department of Clinical and Experimental Medicine, Division of Cell Biology. Linköping University, Faculty of Health Sciences. Instituto de Biologia Molecular y Biotecnologia, La Paz, Bolivia.
Pomeranian Medical University, Szczecin, Poland.
University of Manitoba, Winnipeg, Canada.
Jagiellonian University, Krakow, Poland.
Show others and affiliations
2014 (English)In: Trends in Molecular Medicine, ISSN 1471-4914, E-ISSN 1471-499X, Vol. 20, no 9, 519-528 p.Article, review/survey (Refereed) Published
Abstract [en]

Therapies that selectively target cancer cells for deathhave been the center of intense research recently. Onepotential therapy may involve apoptin proteins, whichare able to induce apoptosis in cancer cells leavingnormal cells unharmed. Apoptin was originally discoveredin the Chicken anemia virus (CAV); however, humangyroviruses (HGyV) have recently been found that alsoharbor apoptin-like proteins. Although the cancer cellspecific activity of these apoptins appears to be wellconserved, the precise functions and mechanisms ofaction are yet to be fully elucidated. Strategies for bothdelivering apoptin to treat tumors and disseminating theprotein inside the tumor body are now being developed,and have shown promise in preclinical animal studies.

Place, publisher, year, edition, pages
2014. Vol. 20, no 9, 519-528 p.
Keyword [en]
anticancer agents; anaphase-promoting complex; CDK2; protein kinase C; protein phosphatase 2A.
National Category
Cell and Molecular Biology Cancer and Oncology
Identifiers
URN: urn:nbn:se:liu:diva-109695DOI: 10.1016/j.molmed.2014.07.003ISI: 000342269500008PubMedID: 25164066OAI: oai:DiVA.org:liu-109695DiVA: diva2:740629
Available from: 2014-08-25 Created: 2014-08-25 Last updated: 2017-12-05Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Authority records BETA

Los, Marek Jan

Search in DiVA

By author/editor
Los, Marek Jan
By organisation
Division of Cell BiologyFaculty of Health Sciences
In the same journal
Trends in Molecular Medicine
Cell and Molecular BiologyCancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 357 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf